{"pmid":32251612,"title":"High-Sensitivity Cardiac Troponin Can Be An Ally in the Fight Against COVID-19.","text":["High-Sensitivity Cardiac Troponin Can Be An Ally in the Fight Against COVID-19.","Circulation","Chapman, Andrew R","Bularga, Anda","Mills, Nicholas L","32251612"],"journal":"Circulation","authors":["Chapman, Andrew R","Bularga, Anda","Mills, Nicholas L"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32251612","week":"202015|Apr 06 - Apr 12","doi":"10.1161/CIRCULATIONAHA.120.047008","keywords":["COVID-19","SARS-CoV-2","coronavirus"],"source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1663352136253046784,"score":7.6679378,"similar":[{"pmid":32169400,"title":"Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis.","text":["Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis.","Prog Cardiovasc Dis","Lippi, Giuseppe","Lavie, Carl J","Sanchis-Gomar, Fabian","32169400"],"journal":"Prog Cardiovasc Dis","authors":["Lippi, Giuseppe","Lavie, Carl J","Sanchis-Gomar, Fabian"],"date":"2020-03-15T11:00:00Z","year":2020,"_id":"32169400","week":"202011|Mar 09 - Mar 15","doi":"10.1016/j.pcad.2020.03.001","keywords":["COVID-19","Coronavirus","Prognosis","Troponin"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1663352133981831168,"score":61.24375},{"pmid":32248521,"title":"Global interim guidance on coronavirus disease 2019 (COVID-19) during pregnancy and puerperium from FIGO and allied partners: Information for healthcare professionals.","text":["Global interim guidance on coronavirus disease 2019 (COVID-19) during pregnancy and puerperium from FIGO and allied partners: Information for healthcare professionals.","In response to the World Health Organization (WHO) statements and international concerns regarding the coronavirus disease 2019 (COVID-19) outbreak, FIGO has issued the following guidance for the management of pregnant women at the four main settings of pregnancy: (1) ambulatory antenatal care in the outpatient clinics; (2) management in the setting of the obstetrical triage; (3) intrapartum management; and (4) postpartum management and neonatal care. We also provide guidance on the medical treatment of pregnant women with COVID-19 infection.","Int J Gynaecol Obstet","Poon, Liona C","Yang, Huixia","Kapur, Anil","Melamed, Nir","Dao, Blami","Divakar, Hema","David McIntyre, H","Kihara, Anne B","Ayres-de-Campos, Diogo","Ferrazzi, Enrico M","Carlo Di Renzo, Gian","Hod, Moshe","32248521"],"abstract":["In response to the World Health Organization (WHO) statements and international concerns regarding the coronavirus disease 2019 (COVID-19) outbreak, FIGO has issued the following guidance for the management of pregnant women at the four main settings of pregnancy: (1) ambulatory antenatal care in the outpatient clinics; (2) management in the setting of the obstetrical triage; (3) intrapartum management; and (4) postpartum management and neonatal care. We also provide guidance on the medical treatment of pregnant women with COVID-19 infection."],"journal":"Int J Gynaecol Obstet","authors":["Poon, Liona C","Yang, Huixia","Kapur, Anil","Melamed, Nir","Dao, Blami","Divakar, Hema","David McIntyre, H","Kihara, Anne B","Ayres-de-Campos, Diogo","Ferrazzi, Enrico M","Carlo Di Renzo, Gian","Hod, Moshe"],"date":"2020-04-06T11:00:00Z","year":2020,"_id":"32248521","week":"202015|Apr 06 - Apr 12","doi":"10.1002/ijgo.13156","keywords":["COVID-19","Coronavirus disease 2019","SARS-CoV-2","management","pneumonia","pregnancy","puerperium"],"source":"PubMed","topics":["Prevention","Treatment"],"weight":1,"_version_":1663352136172306432,"score":46.933105},{"pmid":32249072,"title":"Protecting High-Risk Cardiac Patients During the COVID-19 Outbreak.","text":["Protecting High-Risk Cardiac Patients During the COVID-19 Outbreak.","J Cardiothorac Vasc Anesth","Pisano, Antonio","Landoni, Giovanni","Zangrillo, Alberto","32249072"],"journal":"J Cardiothorac Vasc Anesth","authors":["Pisano, Antonio","Landoni, Giovanni","Zangrillo, Alberto"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32249072","week":"202015|Apr 06 - Apr 12","doi":"10.1053/j.jvca.2020.03.043","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1663352136211103744,"score":45.323402},{"pmid":32183941,"title":"A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2.","text":["A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2.","Effective countermeasures against the recent emergence and rapid expansion of the 2019 novel coronavirus (SARS-CoV-2) require the development of data and tools to understand and monitor its spread and immune responses to it. However, little information is available about the targets of immune responses to SARS-CoV-2. We used the Immune Epitope Database and Analysis Resource (IEDB) to catalog available data related to other coronaviruses. This includes SARS-CoV, which has high sequence similarity to SARS-CoV-2 and is the best-characterized coronavirus in terms of epitope responses. We identified multiple specific regions in SARS-CoV-2 that have high homology to the SARS-CoV virus. Parallel bioinformatic predictions identified a priori potential B and T cell epitopes for SARS-CoV-2. The independent identification of the same regions using two approaches reflects the high probability that these regions are promising targets for immune recognition of SARS-CoV-2. These predictions can facilitate effective vaccine design against this virus of high priority.","Cell Host Microbe","Grifoni, Alba","Sidney, John","Zhang, Yun","Scheuermann, Richard H","Peters, Bjoern","Sette, Alessandro","32183941"],"abstract":["Effective countermeasures against the recent emergence and rapid expansion of the 2019 novel coronavirus (SARS-CoV-2) require the development of data and tools to understand and monitor its spread and immune responses to it. However, little information is available about the targets of immune responses to SARS-CoV-2. We used the Immune Epitope Database and Analysis Resource (IEDB) to catalog available data related to other coronaviruses. This includes SARS-CoV, which has high sequence similarity to SARS-CoV-2 and is the best-characterized coronavirus in terms of epitope responses. We identified multiple specific regions in SARS-CoV-2 that have high homology to the SARS-CoV virus. Parallel bioinformatic predictions identified a priori potential B and T cell epitopes for SARS-CoV-2. The independent identification of the same regions using two approaches reflects the high probability that these regions are promising targets for immune recognition of SARS-CoV-2. These predictions can facilitate effective vaccine design against this virus of high priority."],"journal":"Cell Host Microbe","authors":["Grifoni, Alba","Sidney, John","Zhang, Yun","Scheuermann, Richard H","Peters, Bjoern","Sette, Alessandro"],"date":"2020-03-19T11:00:00Z","year":2020,"_id":"32183941","week":"202012|Mar 16 - Mar 22","doi":"10.1016/j.chom.2020.03.002","keywords":["B cell epitope","COVID-19","SARS-CoV","SARS-CoV-2","T cell epitope","coronavirus","infectious disease","sequence conservation"],"source":"PubMed","topics":["Mechanism","Treatment"],"weight":1,"_version_":1663352133818253313,"score":42.216652}]}